Deep learning in bioinformatics
In the era of big data, transformation of biomedical big data into valuable knowledge has
been one of the most important challenges in bioinformatics. Deep learning has advanced …
been one of the most important challenges in bioinformatics. Deep learning has advanced …
Machine learning in genomic medicine: a review of computational problems and data sets
In this paper, we provide an introduction to machine learning tasks that address important
problems in genomic medicine. One of the goals of genomic medicine is to determine how …
problems in genomic medicine. One of the goals of genomic medicine is to determine how …
A sequence-based global map of regulatory activity for deciphering human genetics
Epigenomic profiling has enabled large-scale identification of regulatory elements, yet we
still lack a systematic mapping from any sequence or variant to regulatory activities. We …
still lack a systematic mapping from any sequence or variant to regulatory activities. We …
Predicting the sequence specificities of DNA-and RNA-binding proteins by deep learning
Knowing the sequence specificities of DNA-and RNA-binding proteins is essential for
developing models of the regulatory processes in biological systems and for identifying …
developing models of the regulatory processes in biological systems and for identifying …
Saturation mutagenesis of twenty disease-associated regulatory elements at single base-pair resolution
M Kircher, C Xiong, B Martin, M Schubach… - Nature …, 2019 - nature.com
The majority of common variants associated with common diseases, as well as an unknown
proportion of causal mutations for rare diseases, fall in noncoding regions of the genome …
proportion of causal mutations for rare diseases, fall in noncoding regions of the genome …
Interpretation of deep learning in genomics and epigenomics
Abstract Machine learning methods have been widely applied to big data analysis in
genomics and epigenomics research. Although accuracy and efficiency are common goals …
genomics and epigenomics research. Although accuracy and efficiency are common goals …
Molecular characterization of familial hypercholesterolemia in Spain
L Palacios, L Grandoso, N Cuevas, E Olano-Martín… - Atherosclerosis, 2012 - Elsevier
Familial hypercholesterolemia (FH), characterized by isolated elevation of plasmatic low-
density lipoprotein (LDL) cholesterol and premature coronary heart disease (CHD), is …
density lipoprotein (LDL) cholesterol and premature coronary heart disease (CHD), is …
Genetics of familial hypercholesterolemia
A Brautbar, E Leary, K Rasmussen, DP Wilson… - Current atherosclerosis …, 2015 - Springer
Familial hypercholesterolemia (FH) is a genetic disorder characterized by elevated low-
density lipoprotein (LDL) cholesterol and premature cardiovascular disease, with a …
density lipoprotein (LDL) cholesterol and premature cardiovascular disease, with a …
Measuring pharmacogene variant function at scale using multiplexed assays
RC Geck, G Boyle, CJ Amorosi… - Annual Review of …, 2022 - annualreviews.org
As costs of next-generation sequencing decrease, identification of genetic variants has far
outpaced our ability to understand their functional consequences. This lack of understanding …
outpaced our ability to understand their functional consequences. This lack of understanding …
Low-density lipoprotein receptor-deficient hepatocytes differentiated from induced pluripotent stem cells allow familial hypercholesterolemia modeling, CRISPR/Cas …
J Caron, V Pène, L Tolosa, M Villaret, E Luce… - Stem Cell Research & …, 2019 - Springer
Background Familial hypercholesterolemia type IIA (FH) is due to mutations in the low-
density lipoprotein receptor (LDLR) resulting in elevated levels of low-density lipoprotein …
density lipoprotein receptor (LDLR) resulting in elevated levels of low-density lipoprotein …